Execlear Interactions
There are 606 drugs known to interact with Execlear (guaifenesin/hydrocodone), along with 16 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 213 are major, 391 are moderate, and 2 are minor.
- View all 606 medications that may interact with Execlear
- View Execlear alcohol/food interactions (1)
- View Execlear disease interactions (16)
Most frequently checked interactions
View interaction reports for Execlear (guaifenesin / hydrocodone) and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- alprazolam
- aspirin
- atomoxetine
- Belsomra (suvorexant)
- buspirone
- celecoxib
- Cholestyramine Light (cholestyramine)
- citalopram
- Claritin (loratadine)
- Crestor (rosuvastatin)
- donepezil
- Dymista (azelastine / fluticasone nasal)
- EpiPen (epinephrine)
- Estradiol Patch (estradiol)
- guanfacine
- hydroxyzine
- losartan
- naltrexone
- Namenda (memantine)
- progesterone
- Provigil (modafinil)
- Rapamune (sirolimus)
- sildenafil
- Strattera (atomoxetine)
- trazodone
- Zyrtec (cetirizine)
Execlear alcohol/food interactions
There is 1 alcohol/food interaction with Execlear (guaifenesin / hydrocodone).
Execlear disease interactions
There are 16 disease interactions with Execlear (guaifenesin / hydrocodone) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
Report options
QR code containing a link to this page
More about Execlear (guaifenesin / hydrocodone)
- Execlear consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.